NEXT Webinar – Chemotherapy and androgen receptor-targeted agents for metastatic castration-resistant prostate cancer
with Professor Ronald de Wit
Tuesday 27th April 2021
APEX (Advances in Prostate Cancer Expert Exchange) is a scientific platform that shares the latest advances in prostate cancer treatment and management, and provides peer-to-peer online education for healthcare professionals.
Since 2016, APEX has been engaging globally recognized experts to share emerging scientific data and detail clinical practice updates. Through a series of webinars, webcasts, expert interviews, and debates with Q&A discussions, APEX aims to create an international network of experts involved in the treatment of men with prostate cancer.
The program of APEX activities is steering-committee led, ensuring that the information delivered is of utmost relevance to the developing treatment landscape in prostate cancer.
APEX is a Sandoz International GmbH educational website for healthcare professionals involved in the treatment of men with prostate cancer. The content of the webcasts and webinars have been developed by healthcare professionals for non-promotional scientific purposes only. The views presented are those of the presenter and not necessarily those of Sandoz International GmbH. These materials are not intended for UK-based healthcare professionals. Medical writing support is provided by Spirit Medical Communications Ltd funded by Sandoz International GmbH.
APEX – For Prostate Cancer Healthcare Professionals
To access the webinar presentations, debates, and interviews with globally recognized experts, as well as webcasts from previous meetings, you will need to register for an account. Registration helps us communicate with you better and permits you to access our event resources and new materials.
Please note that all the information below is necessary for you to access the contents of this website. If you don´t fill out one or some of the fields, we will not be able to register you.
Note that passwords must be at least 8 characters long and contain at least one uppercase letter, one lowercase letter, one number and one special character (such as @$_).